SCHEMBL4600976

SCHEMBL4600976

O=C(N=S(=O)=O)ONC1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 0.38
SMN1; SMN2 Q16637 5/20 0.37
RAB9A P51151 4/20 0.37
NPC1 O15118 4/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP3A4 P08684 1/20 0.37
EPHX2 P34913 1/20 0.37
SIGMAR1 Q99720 3/20 0.33
MMP2 P08253 4/20 0.32
CA12 O43570 3/20 0.32
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA9 Q16790 3/20 0.32
MMP1 P03956 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MMP8 P22894 1/20 0.31
MMP3 P08254 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602852 0.98 EPHX1 (0.41) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL4434964 0.98 EPHX1 (0.41) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL28785853 0.75 EPHX1 (0.45) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL973092 0.73 EPHX1 (0.48) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL27700578 0.73 EPHX1 (0.48) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL11882336 0.71 EPHX1 (0.42) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL27799700 0.70 EPHX1 (0.40) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL1427273 0.70 EPHX1 (0.45) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL22534832 0.70 EPHX1 (0.45) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL6939879 0.70 EPHX1 (0.61) EPHX1SMN1; SMN2RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed